"Game Changing" Technology Enables QR Code Integration with 3D Screen Printing
2022. február 16., szerda, 17:31
NEW YORK, NY / ACCESSWIRE / February 16, 2022 / A study in the Biomedical Journal of Scientific & Technical Research (BJSTR) reports that advances in 3D screen printing allow for mass customization and in-drug labeling of pharmaceuticals with unique identifying information, such as Quick Response (QR) codes, which have been shown to reduce medication errors, improve patient safety, and provide a viable mechanism for remote patient monitoring and identifying counterfeit drugs. The study investigates the progress that has been made in using QR codes for drug labeling, with a specific focus on the potential for using 3D screen printing to expedite QR code integration at the single tablet level. ![]() 3D Screen Printed Tablet with integrated QR code Laxxon Medical Corp. holds the exclusive worldwide license to explore this 3DSP technology for all pharmaceutical applications. "Using this approach, the QR code is part of a one-stop manufacturing process of the tablet," said corresponding author Achim Schneeberger, PhD, CSO of Laxxon Medical. "3DSP could also be used to print API containing QR codes and/or inks which make the tablet easier to identify, harder to counterfeit and increases product safety." About Laxxon Medical Corporation Laxxon Medical holds exclusive worldwide rights to the patented use and application of 3D screen printing technology for the development, manufacture, and commercialization of pharmaceutical dosage forms. With Laxxon Medical"s innovative SPID®-Technology (Screen Printing Innovational Drug Technology), it is possible for the first time to develop tailored-release oral, transdermal, and implantable dosage forms through geometric shaping and heterogeneous distribution of active ingredients within the printed units. Contact Frances Hoggard, Public Relations Manager SOURCE: Laxxon Medical
|
DGAP
-
» DGAP-News: Pacifico Renewables Yield AG combines strong growth and profitability in financial year 2021 – further revenue growth continues
[2022.06.24. 22:04]
-
» DGAP-News: Pacifico Renewables Yield AG verbindet starkes Wachstum und Profitabilität im Geschäftsjahr 2021 - weiteres Umsatzwachstum setzt sich fort
[2022.06.24. 22:04]
-
» DGAP-Adhoc: Allterco JSCo announces intention to repurchase own shares through over-the-counter transactions
[2022.06.24. 18:10]
-
» DGAP-Adhoc: Allterco JSCo kündigt Absicht zum Rückkauf eigener Aktien durch außerbörsliche Transaktionen an
[2022.06.24. 18:10]
-
» DGAP-PVR: flatexDEGIRO AG: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung
[2022.06.24. 17:45]
-
» DGAP-PVR: flatexDEGIRO AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
[2022.06.24. 17:45]
-
» DGAP-DD: Heidelberger Druckmaschinen AG english
[2022.06.24. 16:36]
-
» DGAP-DD: Heidelberger Druckmaschinen AG deutsch
[2022.06.24. 16:36]
-
» DGAP-PVR: Deutsche Bank AG: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung
[2022.06.24. 16:05]